- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07706660
Body-Focused Mindfulness as an Add-on Intervention in Inpatient Alcohol Use Disorder Treatment (MBI-AUD-PL) (MBI-AUD-PL)
Effects of a Body-Focused Mindfulness Intervention Added to Standard Inpatient Alcohol Use Disorder Treatment on Emotion Regulation, Interoceptive Awareness, and Alcohol Craving: A Randomized Controlled Trial
The goal of this clinical trial is to learn if a body-focused mindfulness program can help people with alcohol use disorder (AUD) feel more connected to their bodies and manage their emotions better. The main questions it aims to answer are:
Does the mindfulness program reduce feelings of disconnection from the body (bodily dissociation)? Does it improve awareness of body signals (interoceptive awareness)? Does it lower alcohol craving and reduce the chance of returning to drinking after leaving the hospital? Researchers will compare participants who receive the mindfulness program to participants who receive standard psychoeducation sessions, within the same overall inpatient AUD treatment program.
Participants will:
- Take part in 6 weekly group sessions (90 minutes each) of body-focused mindfulness, which includes breathing exercises, body scan, gentle movement, and group discussion.
- Receive audio recordings of guided mindfulness exercises to practice independently between sessions.
- Complete questionnaires about their emotions, body awareness, and alcohol craving before and after the program.
- Be followed up at 4 weeks, 6 months, and 12 months after leaving the hospital to track their drinking.
Studieoversigt
Status
Intervention / Behandling
Detaljeret beskrivelse
BACKGROUND Alcohol use disorder (AUD) is associated with impaired interoceptive awareness, bodily dissociation, alexithymia, and emotion dysregulation. These deficits are linked to elevated craving and relapse risk. Impaired body-self integration - the degree to which individuals identify with their own body - has been documented in AUD and is associated with emotional processing difficulties (Kopera et al., 2025). While mindfulness-based interventions have shown promise in AUD treatment, programs targeting bodily experience without direct reference to substance use have not been systematically evaluated in inpatient settings.
INTERVENTION The body-focused mindfulness intervention consists of 6 weekly 90-minute group sessions added to standard inpatient AUD treatment. Each session follows a structured format: check-in and review of home practice (10 min), breath-focused meditation (10 min), psychoeducation on mindfulness attitudes (15 min), main body-focused practice - body scan in lying or seated position, mindful walking and stretching (20 min), structured inquiry (15 min), weekly intention setting and home practice assignment (10 min), and 3-minute breathing space (5 min). Participants receive audio recordings of guided mindfulness exercises and are encouraged to practice independently (5-10 minutes daily) between sessions. The intervention does not include direct reference to alcohol use or relapse prevention content. Sessions are delivered by therapists trained in mindfulness-based approaches with personal meditation practice experience.
STRUCTURED INQUIRY Each session includes a structured inquiry component in which the therapist facilitates exploration of participants' bodily experience during practice through open, non-judgmental questions. Inquiry is anchored to bodily experience - the therapist actively returns the conversation to somatic sensations when participants shift toward narrative or abstract reflection.
CONTROL CONDITION The active comparator group receives 6 weekly 90-minute psychoeducation sessions added to the same standard inpatient AUD treatment. Sessions cover standard topics related to alcohol use disorder, recovery, and coping strategies. Delivered by the same therapists as the experimental group. All other components of the inpatient treatment program are identical between groups.
RANDOMIZATION Randomization occurs after 14 days of hospitalization, following completion of the standard introductory psychoeducation program. Computer-generated randomization with sequentially numbered sealed envelopes is used for allocation concealment. Randomization is performed by a person not involved in the delivery of the intervention or outcome assessment.
ASSESSMENT All assessments are conducted in paper-and-pencil format at five time points: baseline (T0, after 14 days of hospitalization, before randomization), post-intervention (T1, before discharge, approximately 6 weeks after T0), and follow-up at 4 weeks (T2), 6 months (T3), and 12 months (T4) post-discharge. After each session, participants in both groups complete a brief paper-based body map referring to their current bodily state. Between sessions, participants are asked to complete a body map when experiencing an episode of alcohol craving.
BODY MAPS Bodily sensation phenomenology is assessed using a paper-based body mapping measure adapted from the InteroMaps framework (Desmedt et al., 2025). Participants mark bodily regions on a printed body outline (front and back view) and rate overall intensity (0-10) and valence (-5 to +5). At T0 and T1, participants complete body maps for six emotions (anxiety, anger, shame, sadness, calm, happiness). After each session, participants complete a brief body map of their current bodily state. Between sessions, a body map is completed during episodes of alcohol craving, with additional ratings of craving intensity (0-10) and difficulty resisting (0-10).
SAMPLE SIZE Sample size was estimated based on Treves et al. (2025), a pre-registered meta-analysis of 29 RCTs (N=2,191) examining the effects of mindfulness-based interventions on self-reported interoception (primary outcome: MAIA-2 total score). The pooled effect across all mindfulness interventions was g=0.31 (95% CI [0.21, 0.42]); the effect for mindfulness-based programs incorporating body scan, breath awareness, mindful movement, and inquiry was g=0.41 (95% CI [0.29, 0.54]). Adopting g=0.41 as the primary assumption, with alpha=0.05 (two-tailed) and 80% statistical power, the required sample is 95 participants per group (N=190 total). Accounting for an anticipated 20% dropout rate, the adjusted target is 119 per group. The planned sample of N=240 (120 per group) provides 80% power at g=0.41 after accounting for dropout, with additional margin for feasibility.
FEASIBILITY REVIEW After enrollment of 100 participants, a feasibility review will assess recruitment rate, protocol adherence, and dropout rate. No interim efficacy analysis is planned. Sample size may be revised upward based on observed attrition. Recruitment will continue beyond N=240 if feasible within the planned recruitment period.
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Andrzej Jakubczyk, MD, PhD
- Telefonnummer: +48506647114
- E-mail: andrzej.jakubczyk@wum.edu.pl
Undersøgelse Kontakt Backup
- Navn: Hubert Suszek, PhD
- Telefonnummer: +48604202554
- E-mail: hubert.suszek@psych.uw.edu.pl
Studiesteder
-
-
Mazovian
-
Warsaw, Mazovian, Polen, 01-045
- Ward XVIII for Alcohol Use Disorder Treatment, Nowowiejski Hospital, Warsaw
-
Underforsker:
- Hubert Suszek, PhD
-
Kontakt:
- Andrzej Jakubczyk, MD, PhD
- Telefonnummer: +48506647114
- E-mail: andrzej.jakubczyk@wum.edu.pl
-
Kontakt:
- Hubert Suszek, PhD
- Telefonnummer: +48604202554
- E-mail: hubert.suszek@psych.uw.edu.pl
-
Ledende efterforsker:
- Andrzej Jakubczyk, MD, PhD
-
Underforsker:
- Maciej Kopera, MD, PhD
-
Underforsker:
- Piotr Januszko, MD, PhD
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
- Diagnosis of Alcohol Use Disorder (DSM-5)
- Currently admitted to the inpatient AUD treatment program at the study ward
- Age 18 years or older
- Written informed consent provided
Exclusion Criteria:
- Refusal to participate or withdrawal of consent
- Severe somatic condition precluding participation in group activities
- Current acute psychotic symptoms
- Severe affective symptoms requiring intensive intervention
- High current suicide risk
- Epileptic seizure within 2 weeks prior to randomization
- Intellectual disability or significant cognitive impairment preventing understanding of or adherence to the study protocol
- Severe personality disorder with current self-harm or other-harm behaviors
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Body-Focused Mindfulness
Participants receive standard inpatient AUD treatment plus 6 weekly 90-minute body-focused mindfulness group sessions (breath awareness, body scan, mindful movement, and structured inquiry).
Sessions are delivered in an open circular group format without direct reference to alcohol use.
Participants receive audio recordings of guided mindfulness exercises and are encouraged to practice independently (5-10 minutes daily) between sessions.
|
Six weekly 90-minute group sessions incorporating breath-focused meditation, body scan (lying and seated positions), mindful movement and stretching, and structured inquiry.
Delivered in an open circular group format by therapists trained in mindfulness-based approaches.
No direct reference to alcohol use.
Participants receive audio recordings of guided mindfulness exercises and are encouraged to practice independently (5-10 minutes daily) between sessions.
|
|
Aktiv komparator: Psychoeducation (Active Comparator)
Participants receive standard inpatient AUD treatment plus 6 weekly 90-minute psychoeducation group sessions covering standard topics related to alcohol use disorder, recovery, and coping strategies.
All other components of the treatment program are identical to the experimental group.
|
Six weekly 90-minute group psychoeducation sessions added to standard inpatient AUD treatment.
Sessions cover standard topics related to alcohol use disorder, recovery, and coping strategies.
Delivered by the same therapists as the experimental group.
All other components of the inpatient treatment program are identical between groups.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Multidimensional Assessment of Interoceptive Awareness, Version 2 (MAIA-2) - total score
Tidsramme: Baseline and 6 weeks
|
The Multidimensional Assessment of Interoceptive Awareness, Version 2 (MAIA-2) is a 37-item self-report questionnaire assessing eight dimensions of interoceptive awareness including noticing, attention regulation, emotional awareness, self-regulation, body listening, and trusting bodily sensations (Mehling et al., 2018).
Total score ranges from 0 to 185, with higher scores indicating greater interoceptive awareness (better outcome).
|
Baseline and 6 weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Scale of Body Connection - Bodily Dissociation subscale (SBC-BD)
Tidsramme: Baseline and 6 weeks
|
The Scale of Body Connection (SBC) is a 20-item measure on a 5-point Likert scale (1 = "not at all" to 5 = "all of the time") assessing bodily experience. The scale comprises two independent subscales:
|
Baseline and 6 weeks
|
|
Difficulties in Emotion Regulation Scale (DERS) - total score
Tidsramme: Baseline and 6 weeks
|
The Difficulties in Emotion Regulation Scale (DERS) is a 36-item self-report questionnaire measuring difficulties in emotion regulation across six dimensions: non-acceptance of emotional responses, difficulty engaging in goal-directed behaviors, impulse control difficulties, lack of emotional awareness, limited access to regulation strategies, and lack of emotional clarity.
Total score ranges from 36 to 180, with higher scores indicating greater difficulties in emotion regulation (worse outcome).
|
Baseline and 6 weeks
|
|
Toronto Alexithymia Scale (TAS-20) - total score
Tidsramme: Baseline and 6 weeks
|
The Toronto Alexithymia Scale (TAS-20) is a 20-item self-report measure of alexithymia assessing three dimensions: difficulty identifying feelings, difficulty describing feelings, and externally oriented thinking.
Total score ranges from 20 to 100, with higher scores indicating greater alexithymia (worse outcome).
|
Baseline and 6 weeks
|
|
Dissociative Experiences Scale (DES) - total score
Tidsramme: Baseline and 6 weeks
|
The Dissociative Experiences Scale (DES) is a 28-item self-report measure of the frequency of dissociative experiences.
Total score ranges from 0 to 100, with higher scores indicating greater frequency of dissociation (worse outcome).
|
Baseline and 6 weeks
|
|
Penn Alcohol Craving Scale (PACS)
Tidsramme: Baseline and 6 weeks
|
The Penn Alcohol Craving Scale (PACS) is a 5-item self-report measure assessing alcohol craving frequency, intensity, duration, and ability to resist.
Total score ranges from 0 to 30, with higher scores indicating greater alcohol craving (worse outcome).
|
Baseline and 6 weeks
|
|
Cognitive and Affective Mindfulness Scale Revised - Polish version (CAMS-R-PL)
Tidsramme: Baseline and 6 weeks
|
The Cognitive and Affective Mindfulness Scale-Revised Polish version (CAMS-R-PL) is a 10-item self-report measure on a 4-point Likert scale (1 = Rarely/Never, 2 = Sometimes, 3 = Often, 4 = Almost Always) assessing present-moment awareness, attention, intention, and non-judgment as a unidimensional construct of dispositional mindfulness.
Total score ranges from 10 to 40, with higher scores indicating greater dispositional mindfulness (better outcome).
|
Baseline and 6 weeks
|
|
Reflective Functioning Questionnaire (RFQ)
Tidsramme: Baseline and 6 weeks
|
The Reflective Functioning Questionnaire (RFQ) is an 8-item self-report measure assessing reflective functioning across two subscales: Certainty about mental states (RFQ-C, higher scores indicate hypermentalizing) and Uncertainty about mental states (RFQ-U, higher scores indicate hypomentalizing).
Both subscales use a recoded scoring procedure.
Higher scores on either subscale indicate more maladaptive mentalizing.
Developed as a brief screening measure of mentalization capacity (Fonagy et al., 2016).
|
Baseline and 6 weeks
|
|
Beck Depression Inventory II (BDI-II)
Tidsramme: Baseline and 6 weeks
|
The Beck Depression Inventory II (BDI-II) is a 21-item self-report measure of depression severity over the past two weeks.
Total score ranges from 0 to 63, with higher scores indicating greater depressive symptoms (worse outcome).
|
Baseline and 6 weeks
|
|
State-Trait Anxiety Inventory (STAI)
Tidsramme: Baseline and 6 weeks
|
The State-Trait Anxiety Inventory (STAI) measures state anxiety (current anxiety level) and trait anxiety (general tendency to experience anxiety).
Each subscale ranges from 20 to 80, with higher scores indicating greater state or trait anxiety (worse outcome).
|
Baseline and 6 weeks
|
|
Self-Body Identification - Circles measure
Tidsramme: Baseline and 6 weeks
|
The Self-Body Identification - Circles measure is a visual measure of the degree of psychological identification of the self with one's own body, using overlapping circles to represent the perceived overlap between self and body.
The scale consists of 7 pairs of circles (modified version of the Inclusion of Other in the Self Scale; Aron et al., 1992; Suszek et al., 2026).
Total score ranges from 1 (lowest level of identification with the body) to 7 (highest level of identification with the body), with higher scores indicating stronger self-body identification (better outcome).
Validated in AUD populations (Kopera et al., 2025).
|
Baseline and 6 weeks
|
|
Timeline Follow-Back (TLFB) - alcohol use
Tidsramme: 4 weeks, 6 months, and 12 months post-discharge
|
The Timeline Follow-Back (TLFB) is a structured retrospective interview assessing daily alcohol use over a specified period.
Outcomes include percentage of days abstinent (PDA, ranging from 0 to 100%) and mean drinks per drinking day (MDDD, ranging from 0 upward), with higher abstinence and lower MDDD indicating better clinical outcome.
Used to assess alcohol consumption and relapse patterns after hospital discharge.
Primary follow-up outcome for long-term clinical effectiveness.
|
4 weeks, 6 months, and 12 months post-discharge
|
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Body Maps - Bodily Sensation Phenomenology (paper-based measure)
Tidsramme: Baseline and 6 weeks
|
The Body Maps - Bodily Sensation Phenomenology is a paper-based body mapping measure in which participants mark bodily regions associated with current emotional experience on a printed body outline (front and back view) and rate overall intensity (0-10, with higher scores indicating stronger bodily sensations) and valence (-5 to +5, with higher scores indicating more positive valence).
Administered at baseline and post-intervention for eight states: six basic emotions (happiness, fear, anger, sadness, disgust, surprise), neutral state, and alcohol craving.
Adapted from the InteroMaps framework (Desmedt et al., 2025).
|
Baseline and 6 weeks
|
|
Post-Session Single-Item Measures (three NRS items)
Tidsramme: After each session, up to 6 weeks
|
Three single-item Numeric Rating Scale (NRS) measures, each ranging from 0 to 10, are administered immediately after each session to participants in both groups.
Item 1 assesses mindful awareness (0 = not at all able to notice what was happening inside them, 10 = fully able to notice; higher scores indicate better outcome).
Item 2 assesses interoceptive awareness (0 = did not feel their body at all clearly, 10 = felt their body very clearly; higher scores indicate better outcome).
Item 3 assesses current alcohol craving (0 = not at all craving alcohol, 10 = unbearably craving; higher scores indicate worse outcome).
Items 1 and 2 refer to the session experience (retrospective), while Item 3 refers to the current moment (post-session state).
Administered to both groups to allow direct comparison of session effects between body-focused mindfulness and psychoeducation conditions.
|
After each session, up to 6 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Andrzej Jakubczyk, MD, PhD, Medical University of Warsaw
- Studiestol: Marcin Wojnar, MD, PhD, Medical University of Warsaw
Publikationer og nyttige links
Generelle publikationer
- Mehling WE, Acree M, Stewart A, Silas J, Jones A. The Multidimensional Assessment of Interoceptive Awareness, Version 2 (MAIA-2). PLoS One. 2018 Dec 4;13(12):e0208034. doi: 10.1371/journal.pone.0208034. eCollection 2018.
- Price CJ, Thompson EA. Measuring dimensions of body connection: body awareness and bodily dissociation. J Altern Complement Med. 2007 Nov;13(9):945-53. doi: 10.1089/acm.2007.0537.
- Cheng SC, Thompson EA, Price CJ. The Scale of Body Connection: A Multisample Study to Examine Sensitivity to Change Among Mind-Body and Bodywork Interventions. J Integr Complement Med. 2022 Jul;28(7):600-606. doi: 10.1089/jicm.2021.0397. Epub 2022 Apr 22.
- Treves IN, Chen YY, Wilson CL, Verdonk C, Qina'au J, Pustejovsky JE, Goldberg SB, Mehling W, Schuman-Olivier Z, Khalsa SS. Minding the Body: A Meta-analysis of the Effects of Mindfulness Meditation Training on Self-reported Interoception. Res Sq [Preprint]. 2025 Jun 4:rs.3.rs-6792067. doi: 10.21203/rs.3.rs-6792067/v1.
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 2403/2026/09
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Alkohol-relaterede lidelser
-
University Hospital, Clermont-FerrandAfsluttetOral Health Related Quality of Life (OHRQoL)Frankrig
-
Riyadh Elm UniversityAfsluttetOral Health Related Quality of Life OHRQoLSaudi Arabien
-
University of LisbonUniversidade Nova de LisboaAfsluttetGingivitis | Maloklusion | Early Childhood Caries (ECC) | Oral Health Related Quality of Life (OHRQoL) | Traumatiske tandskaderPortugal
-
University of MalayaUkendtTranspalatal bue (TPA) | Oral Health Related Quality of Life (OHRQoL) | Oral Health Impact Profile Short Version 14 (OHIP 14) | Ortodontiske smerter | Tredimensionel (3D) ortodontisk enhedMalaysia
-
University of MilanAssociazione Italiana Mowat Wilson (Mowat Wilson Italian Association)Ikke rekrutterer endnuPeriodontale sygdomme | Caries i tænderne | Tandsygdomme | Maloklusion | Kraniofaciale abnormiteter | Tandabnormiteter | Oral slimhindesygdom | Oral Health Related Quality of Life (OHRQoL) | Søvnrelateret vejrtrækningsforstyrrelse | Mowat-Wilson SyndromItalien
-
National Human Genome Research Institute (NHGRI)Children's National Research Institute; Uniformed Services University of...RekrutteringProteus syndrom | PIK3CA Related Overgrowth SpectrumForenede Stater
Kliniske forsøg med Body-Focused Mindfulness Intervention
-
Nova Scotia Health AuthorityAfsluttetBinge-Eating Disorder | SpiseforstyrrelseCanada
-
Beth Israel Deaconess Medical CenterAfsluttetKronisk smerte | Kronisk smertesyndromForenede Stater
-
University of Texas at AustinNational Heart, Lung, and Blood Institute (NHLBI)AfsluttetForhøjet blodtrykForenede Stater
-
Beth Israel Deaconess Medical CenterRekrutteringKronisk smerte | Kronisk smertesyndrom | Gentagen stressskadeForenede Stater
-
Beth Israel Deaconess Medical CenterRekrutteringLang COVID | COVID-langdistance | Post-akutte følgesygdomme af COVID-19Forenede Stater
-
Massachusetts General HospitalHarvard Medical School (HMS and HSDM)AfsluttetKolorektal cancer | Seksuel dysfunktion | Anal kræftForenede Stater
-
The University of Hong KongRekruttering
-
Montefiore Medical CenterNational Center for Advancing Translational Sciences (NCATS); Hureka TechnologiesIkke rekrutterer endnuInflammatoriske tarmsygdomme | Crohns sygdom | Colitis ulcerosaForenede Stater
-
Rush University Medical CenterAfsluttetDepression | AngstForenede Stater
-
Medipol UniversityTilmelding efter invitationMastektomi | BrystkræftoverleverKalkun